Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Accumulated Expenses (2016 - 2025)

Phibro Animal Health has reported Accumulated Expenses over the past 13 years, most recently at $128.4 million for Q4 2025.

  • Quarterly results put Accumulated Expenses at $128.4 million for Q4 2025, up 269.79% from a year ago — trailing twelve months through Dec 2025 was $128.4 million (up 269.79% YoY), and the annual figure for FY2025 was $51.8 million, down 41.7%.
  • Accumulated Expenses for Q4 2025 was $128.4 million at Phibro Animal Health, up from $20.8 million in the prior quarter.
  • Over the last five years, Accumulated Expenses for PAHC hit a ceiling of $128.4 million in Q4 2025 and a floor of $735000.0 in Q2 2021.
  • Median Accumulated Expenses over the past 5 years was $51.8 million (2025), compared with a mean of $51.0 million.
  • Biggest five-year swings in Accumulated Expenses: soared 4563.67% in 2022 and later crashed 82.98% in 2023.
  • Phibro Animal Health's Accumulated Expenses stood at $72.8 million in 2021, then fell by 1.62% to $71.7 million in 2022, then grew by 5.05% to $75.3 million in 2023, then crashed by 53.86% to $34.7 million in 2024, then skyrocketed by 269.79% to $128.4 million in 2025.
  • The last three reported values for Accumulated Expenses were $128.4 million (Q4 2025), $20.8 million (Q3 2025), and $51.8 million (Q2 2025) per Business Quant data.